A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
- Status
- WITHDRAWN
- Phase
- PHASE3
Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
- Status
- RECRUITING
- Phase
- PHASE2
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Experimental Medication BMS-986235 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1